NeoPhore (AgeTech UK) Biomed
Discovering drugs that create neoantigens for effective cancer immune response/treatment.
Investor Type:
N/A
Technology:
AgeTech Companies
Investment Stage:
N/A
Founded Date:
N/A
Industry:
UK AgeTech 2020
Employee Number:
N/A
Funding Status:
N/A
Number Of Exists:
N/A
Headquarters:
United Kingdom